K-001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for K-001, covering 2017-01-06 to 2020-11-12. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer [Phase 2, Phase 3]